These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4151386)

  • 41. Effect of drugs stimulating dopaminergic system on phosphodiesterase activity in rat striatum.
    Janiec W; Piekarska T; Szczypior M; Misterkiewicz E
    Pol J Pharmacol Pharm; 1976; 28(6):631-4. PubMed ID: 189292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine receptors and cholinergic neurons in the rat neostriatum.
    Guyenet PG; Javoy F; Agid Y; Beaujouan JC; Glowinski J
    Adv Neurol; 1975; 9():43-51. PubMed ID: 238376
    [No Abstract]   [Full Text] [Related]  

  • 43. Lack of effect of intraventricular 6-hydroxydopamine pretreatment on rat striatal cholinergic parameters.
    Consolo S; Ladinsky H; Peri G; Samanin R; Ghezzi D
    Brain Res; 1974 Sep; 78(2):327-30. PubMed ID: 4852633
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
    Miller R; Horn A; Iversen L; Pinder R
    Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 47. Dopamine and apomorphine do not modulate the uptake of [3H]D-aspartate in the rat striatum in-vitro.
    O'Connor I; Cowburn RF; Hardy JA; Fowler CJ
    J Pharm Pharmacol; 1988 Apr; 40(4):307-8. PubMed ID: 2900322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way.
    Stoof JC; Booij J; Drukarch B; Wolters EC
    Eur J Pharmacol; 1992 Mar; 213(3):439-43. PubMed ID: 1618282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of benapyrzine, a new antiparkinson drug, on dopamine uptake into corpus striatum.
    Palfreyman MG; Palfreyman ES; Clark MS
    Eur J Pharmacol; 1974 Oct; 28(2):379-83. PubMed ID: 4418659
    [No Abstract]   [Full Text] [Related]  

  • 50. Age-related decrease in apomorphine modulation of acetylcholine release from rat striatal slices.
    Thompson JM; Makino CL; Whitaker JR; Joseph JA
    Brain Res; 1984 May; 299(1):169-73. PubMed ID: 6722565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of a 'cholinergic link' in the apomorphine-induced feedback inhibition of dopamine synthesis in rat striatum.
    Van Zwieten-Boot BJ; Petri-Bot A
    Eur J Pharmacol; 1976 Oct; 39(2):245-50. PubMed ID: 976319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increase in striatal acetylcholine levels in vivo by piribedil a new dopamine receptor stimulant.
    Ladinsky H; Consolo S; Garattini S
    Life Sci; 1974 Apr; 14(7):1251-60. PubMed ID: 4823638
    [No Abstract]   [Full Text] [Related]  

  • 53. Ontogenesis of dopaminergic-cholinergic interactions in the rat striatum: a neurochemical study.
    Coyle JT; Campochiaro P
    J Neurochem; 1976 Sep; 27(3):673-8. PubMed ID: 9481
    [No Abstract]   [Full Text] [Related]  

  • 54. Decrease in rat striatal acetylcholine levels by some direct- and indirect-acting dopaminergic antagonists.
    Consolo S; Ladinsky H; Bianchi S
    Eur J Pharmacol; 1975; 33(2):345-51. PubMed ID: 1183479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of morphine's effect on striatal dopamine metabolism in rats treated with a low dose of apomorphine or agents increasing serotonin transmission.
    Spampinato U; Invernizzi R; Nowakowska E; Samanin R
    Biochem Pharmacol; 1984 Jan; 33(1):163-5. PubMed ID: 6704139
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM; Flemenbaum A
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract]   [Full Text] [Related]  

  • 57. Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine.
    MacKenzie RG; Stachowiak MK; Zigmond MJ
    Eur J Pharmacol; 1989 Sep; 168(1):43-52. PubMed ID: 2511032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition by d-amphetamine of the electrically evoked release of [3H]acetylcholine from slices of the rat striatum: involvement of dopamine receptors.
    Cantrill RC; Arbilla S; Langer SZ
    Eur J Pharmacol; 1983 Jan; 87(1):167-8. PubMed ID: 6840186
    [No Abstract]   [Full Text] [Related]  

  • 59. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine.
    Stadler H; Lloyd KG; Gadea-Ciria M; Bartholini G
    Brain Res; 1973 Jun; 55(2):476-80. PubMed ID: 4351628
    [No Abstract]   [Full Text] [Related]  

  • 60. Biochemical and behavioral antagonism between fenfluramine and apomorphine in rats.
    Jori A; Cecchetti G; Ghezzi D; Samanin R
    Eur J Pharmacol; 1974 May; 26(2):179-83. PubMed ID: 4859224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.